Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TEX21P (Testis expressed 21, pseudogene) is annotated as a pseudogene in the human genome[1]. Pseudogenes are segments of DNA that resemble functional genes but typically do not encode an active protein product due to mutations or truncations. There is no evidence for TEX21P being expressed as a functional protein nor being associated with biological processes or disease mechanisms. It is not considered a therapeutic target, and there are no known drugs or clinical biomarkers related to this gene. Its only established characteristic is sequence similarity to other testis-expressed genes, but it remains non-functional in the current scientific literature[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed 21, pseudogene (TEX21P).